The biopharmaceutical processing equipment & consumables market is witnessing robust growth, driven by the rising production of biologics, biosimilars, vaccines, and advanced cell and gene therapies.

Swiss pharma giant Novartis NVS announced an agreement to acquire privately held UK-based biotechnology company Myricx Bio, ...

Gilead Sciences, Inc. GILD recently won FDA approval for the label expansion of breast cancer drug Trodelvy (sacituzumab ...

Shell Plc engages in the business of producing oil and natural gas. It operates through the following segments: Integrated Gas, Upstream, Marketing, Chemicals and Products, Renewables and Energy ...